$ONCO #Oncopeptides AB Oncopeptides - Further details on the HORIZON data: More details around HORIZON data out at EHA Reduced mDoR in triple class refractory patients AA filing late June should provide some share price relief https://t.co/y35XbHoeAs #equity #stocks